Treatment Information

Back

Colon Cancer treatment details. Chemotherapy, Biologic therapy.

Salvatore Hospital, L’Aquila, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:4City/State/Province:L’Aquila
Treatments:Chemotherapy, Biologic therapyHospital:Salvatore Hospital
Drugs:Journal:Link
Date:Oct 2010

Description:

Patients:
This phase II study involved 50 metastatic colorectal cancer patients with a median age of 63 years; 31 were male.

Treatment:
Patients were treated with a combination of the chemotherapy agents 5-fluorouracil, irinotecan, and oxaliplatin, as well as the biologic therapy agent bevacizumab.

Toxicities:
There was one case of grade 4 liver toxicity, which was the most severe adverse event reported. Grade 3 diarrhea, nausea/vomiting, and mucositis (inflammation of the lining of the GI tract) were also reported.

Results:
The median overall survival in this study was 28 months.

Correspondence: Dr. Enrico Ricevuto; email: [email protected]



Back